Measles (map05162) |
1.02E-08 |
295.14 |
Influenza A (map05164) |
1.02E-08 |
252.18 |
Herpes simplex virus 1 infection (map05168) |
7.16E-10 |
177.20 |
Epstein-Barr virus infection (map05169) |
4.82E-07 |
156.14 |
TNF signaling pathway (map04668) |
1.11E-07 |
153.86 |
Coronavirus disease (map05171) |
3.78E-07 |
150.32 |
RIG-I-like receptor signaling pathway (map04622) |
3.68E-04 |
120.34 |
NOD-like receptor signaling pathway (map04621) |
9.37E-06 |
119.63 |
Legionellosis (map05134) |
1.77E-05 |
118.99 |
Hepatitis C (map05160) |
1.79E-05 |
118.31 |
TNF signaling pathway (map04668) |
8.61E-05 |
116.25 |
Primary immunodeficiency (map05340) |
2.17E-03 |
116.00 |
Allograft rejection (map05330) |
2.17E-03 |
116.00 |
Amoebiasis (map05146) |
2.13E-06 |
111.38 |
African trypanosomiasis (map05143) |
1.50E-04 |
111.14 |
Rheumatoid arthritis (map05323) |
3.12E-06 |
110.93 |
Legionellosis (map05134) |
1.12E-03 |
105.75 |
Antigen processing and presentation (map04612) |
5.58E-04 |
100.66 |
JAK-STAT signaling pathway (map04630) |
1.07E-06 |
96.92 |
NF-kappa B signaling pathway (map04064) |
3.68E-04 |
92.76 |